Press Release





Plerixafor (AMD3100)

We are receiving a lot of e mails about the recent press releases, regarding our laboratory experiments with Plerixafor in a pancreatic cancer model, so we are unable to reply to them all, individually.  
We hope that the first trial of this type of approach in patients with pancreatic cancer may start in the latter part of 2014, but it will then still be some time before we know whether it will actually be successful in patients.
As we do not know yet whether this approach will have any effect in patients, we encourage people to access treatments that are available to them, as close to home as possible.
Please contact the CRUK Cancer Information Nurses at 0808 800 4040 or if you require any further information.

Thank you for your interest in our group’s work.